High prevalence of aspartylglycosaminuria among school-age children in eastern Finland.
A high prevalence of the lysosomal storage disease aspartylglycosaminuria was found in a study of four birth cohorts of 12882 children in eastern Finland. Using school achievement tests and registers of mentally retarded individuals, 178 mentally retarded children were identified. Randomized urine samples from 151 of the 178 retarded children and from 101 healthy children were analyzed quantitatively for aspartylglucosamine by high-performance liquid chromatography. The results identified three affected individuals in the retarded group indicating an exceptionally high prevalence of aspartylglycosaminuria (1:3643) in the study population, consistent with a carrier frequency of 1:30. The 95% confidence limits for the prevalence are 1:4 352-1:16389. This is the highest prevalence described for any glycoproteinosis in any population and comparable to the incidence figures of the most common lysosomal storage diseases, Gaucher disease type I and Tay-Sachs disease among Ashkenazi Jews. In the study group, aspartylglycosaminuria was, after trisomy 21 (n = 19) and the fragile X syndrome (n = 6), the most common genetic cause for mental retardation.
Mononen
T
T
Department of Clinical Chemistry, Kuopio University Central Hospital, Finland.
Mononen
I
I
Matilainen
R
R
Airaksinen
E
E
D000117:Acetylglucosamine / Q000031:analogs & derivatives* / Q000652:urine; D054880:Aspartylglucosaminuria; D002648:Child; D005387:Finland / Q000453:epidemiology; D006801:Humans; D008607:Intellectual Disability / Q000150:complications / Q000235:genetics / Q000652:urine*; D008661:Metabolism, Inborn Errors / Q000150:complications / Q000453:epidemiology; D015995:Prevalence
C000009:N-acetylglucosaminylasparagine; D000117:Acetylglucosamine